+关注
460e6297
暂无个人介绍
IP属地：未知
505
关注
19
粉丝
0
主题
0
勋章
主贴
热门
460e6297
2021-08-20
Like
抱歉，原内容已删除
460e6297
2021-11-18
Like
抱歉，原内容已删除
460e6297
2021-10-30
Like
抱歉，原内容已删除
460e6297
2021-08-23
Like
抱歉，原内容已删除
460e6297
2021-08-12
Like
抱歉，原内容已删除
460e6297
2021-09-12
Like
抱歉，原内容已删除
460e6297
2021-10-08
Like
抱歉，原内容已删除
460e6297
2021-08-30
Like
抱歉，原内容已删除
460e6297
2021-07-15
Like please
抱歉，原内容已删除
460e6297
2021-10-28
Like
抱歉，原内容已删除
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3581839766583119","uuid":"3581839766583119","gmtCreate":1618767577896,"gmtModify":1623598254416,"name":"460e6297","pinyin":"wooloo123","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":19,"headSize":505,"tweetSize":175,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.38%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.06%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":602413888,"gmtCreate":1639055930295,"gmtModify":1639056329797,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581839766583119","idStr":"3581839766583119"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602413888","repostId":"1163175495","repostType":4,"repost":{"id":"1163175495","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639056901,"share":"https://www.laohu8.com/m/news/1163175495?lang=zh_CN&edition=full","pubTime":"2021-12-09 21:35","market":"us","language":"en","title":"Toplines Before US Market Open on Thursday<blockquote>周四美国市场开盘前的营收</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1163175495","media":"Tiger Newspress","summary":"U.S. stock-index futures hold solid losses after initial jobless claims come in at 184,000.\nAt 8:34 ","content":"<p>U.S. stock-index futures hold solid losses after initial jobless claims come in at 184,000.</p><p><blockquote>首次申请失业救济人数达到184,000人后，美国股指期货继续下跌。</blockquote></p><p> At 8:34 a.m. ET, Dow e-minis were down 168 points, or 0.47%, S&P 500 e-minis were down 21 points, or 0.45%, and Nasdaq 100 e-minis were down 80.5 points, or 0.49%.</p><p><blockquote>截至美国东部时间上午8:34，道指e-minis下跌168点，跌幅0.47%，标普500 e-minis下跌21点，跌幅0.45%，纳斯达克100 e-minis下跌80.5点，跌幅0.49%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/e48b5d3abdc91abde117585acac09b40\" tg-width=\"401\" tg-height=\"184\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Weekly jobless claims reached tumbled last week, reaching a fresh 52-year low as the U.S. jobs market climbs out of its pandemic-era hole, the Labor Department reported Thursday.</p><p><blockquote>美国劳工部周四报告称，随着美国就业市场走出大流行时期的困境，上周每周申请失业救济人数大幅下降，创下52年来的新低。</blockquote></p><p> Initial filings for unemployment insurance totaled 184,000 for the week ended Dec. 4, the lowest going back to Sept. 6, 1969, which saw 182,000.</p><p><blockquote>截至12月4日当周，首次申请失业保险的人数为184,000人，是自1969年9月6日（182,000人）以来的最低水平。</blockquote></p><p> Initial claims for unemployment insurance were expected to total 211,000 for the week ended Dec. 4, according to a Dow Jones economist survey.</p><p><blockquote>根据道琼斯经济学家的调查，截至12月4日当周，首次申请失业保险的人数预计为21.1万人。</blockquote></p><p> Meanwhile, a deal to avert U.S. debt default and raise the federal government's $28.9 trillion debt limit will be tested on Thursday in the Senate when the full chamber votes on whether to approve the measure.</p><p><blockquote>与此同时，一项避免美国债务违约并提高联邦政府28.9万亿美元债务上限的协议将于周四在参议院接受测试，届时众议院全体成员将就是否批准该措施进行投票。</blockquote></p><p> <b>Stocks making the biggest moves premarket: </b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <b>GameStop(GME)</b> – GameStop shares slid 5.6% in premarket trading after the videogame retailer posted a wider loss compared with a year earlier and also disclosed an August subpoena from the SEC involving the trading of its shares.</p><p><blockquote><b>游戏驿站(GME)</b>-游戏驿站股价在盘前交易中下跌5.6%，此前这家视频游戏零售商公布了与去年同期相比更大的亏损，并披露了美国证券交易委员会8月份发出的涉及其股票交易的传票。</blockquote></p><p> <b>Lucid Group(LCID)</b> – Lucid shares tumbled 6.5% in the premarket after the electric vehicle maker announced a $1.75 billion offering of convertible senior notes.</p><p><blockquote><b>Lucid集团(LCID)</b>–电动汽车制造商Lucid宣布发行17.5亿美元的可转换优先票据后，该公司股价在盘前下跌6.5%。</blockquote></p><p> <b>FuboTV(FUBO) </b>– The video streaming company was rated “overweight” in new coverage at J.P. Morgan Securities, based on Fubo’s sports-centered offerings as a differentiating factor. The stock jumped 2.8% in premarket action.</p><p><blockquote><b>FuboTV（富博）</b>-该视频流媒体公司在摩根大通证券的新报道中被评为“跑赢大盘”，这是基于富博以体育为中心的产品作为差异化因素。该股在盘前上涨2.8%。</blockquote></p><p> <b>CVS Health(CVS)</b> – The drug store operator issued new guidance ahead of its investor day, saying it expects a 2022 adjusted profit of $8.10 to $8.30 per share compared with an $8.24 consensus estimate and better-than-expected revenue. CVS also raised its 2021 outlook, and the shares rallied 2.6% in the premarket.</p><p><blockquote><b>CVS健康(CVS)</b>–这家药店运营商在投资者日之前发布了新的指引，称预计2022年调整后每股利润为8.10美元至8.30美元，而市场普遍预期为8.24美元，收入好于预期。CVS还上调了2021年展望，股价盘前上涨2.6%。</blockquote></p><p> <b>Hormel(HRL)</b> – The food producer beat estimates by a penny with quarterly earnings of 51 cents per share, and revenue that also topped Wall Street forecasts. Hormel saw double-digit growth across all of its business segments, and shares rose 1% in premarket trading.</p><p><blockquote><b>荷美尔(HRL)</b>–这家食品生产商的季度收益为每股51美分，超出预期1美分，收入也超出了华尔街的预期。荷美尔所有业务部门均实现两位数增长，股价在盘前交易中上涨1%。</blockquote></p><p> <b>RH(RH)</b> – The company formerly known as Restoration Hardware reported adjusted quarterly earnings of $7.03 per share, 40 cents above estimates, while the luxury home furnishings retailer’s revenue beat forecasts. RH also lifted the low end of its revenue outlook. RH surged 11% in premarket action.</p><p><blockquote><b>相对湿度（相对湿度）</b>-该公司前身为Restoration Hardware，报告调整后季度收益为每股7.03美元，比预期高出40美分，而这家豪华家居用品零售商的收入超出预期。RH还上调了收入预期的下限。RH在盘前交易中飙升11%。</blockquote></p><p> <b>Rent The Runway(RENT)</b> – Rent The Runway tumbled 8.2% in the premarket after the fashion rental company posted a loss that was wider than a year ago and reported subscriber numbers that have not yet returned to pre-pandemic levels. Sales did surge 66% over the same quarter a year ago.</p><p><blockquote><b>租用跑道（Rent）</b>–Rent The Runway在盘前下跌8.2%，此前这家时尚租赁公司公布的亏损幅度超过一年前，且订户数量尚未恢复到大流行前的水平。销售额确实比去年同期猛增了66%。</blockquote></p><p> <b>Apple(AAPL)</b> – Apple won an appeals court decision that delays changes to its App Store. An earlier ruling had ordered Apple to allow developers to offer payment alternatives outside of the App Store, stemming from its legal dispute with “Fortnite” developer Epic Games. Separately, Apple is closing in on a $3 trillion valuation, which will be achieved when the share price hits $182.86.</p><p><blockquote><b>苹果(AAPL)</b>-苹果赢得了上诉法院的裁决，推迟了对其应用商店的更改。早些时候的一项裁决命令苹果允许开发者在App Store之外提供支付替代方案，源于其与《堡垒之夜》开发商Epic Games的法律纠纷。另外，苹果的估值接近3万亿美元，这一估值将在股价达到182.86美元时实现。</blockquote></p><p> <b>Amazon(AMZN)</b> – Italy's antitrust said on Thursday it had fined e-commerce giant Amazon 1.13 billion euros ($1.28 billion) for alleged abuse of market dominance.</p><p><blockquote><b>亚马逊(AMZN)</b>-意大利反垄断机构周四表示，已对电商巨头亚马逊处以11.3亿欧元（12.8亿美元）的罚款，原因是其涉嫌滥用市场支配地位。</blockquote></p><p> <b>AstraZeneca(AZN)</b> – The drug maker’s Covid-19 antibody treatment won FDA approval for patients who cannot achieve adequate protection from vaccination.</p><p><blockquote><b>阿斯利康(AZN)</b>-该制药商的Covid-19抗体治疗获得FDA批准，用于无法通过疫苗接种获得足够保护的患者。</blockquote></p><p> <b>LabCorp(LH)</b> – The medical lab operator announced a number of steps to enhance shareholder value, including the initiation of a dividend in the second quarter of 2022 and the authorization of a $2.5 billion share repurchase program.</p><p><blockquote><b>LabCorp(LH)</b>–这家医学实验室运营商宣布了一系列提高股东价值的措施，包括在2022年第二季度启动股息以及授权25亿美元的股票回购计划。</blockquote></p><p> <b>UiPath(PATH)</b> – UiPath stock dropped 1.5% in premarket trading even as the “software robots” provider’s quarterly results topped Wall Street expectations.</p><p><blockquote><b>UiPath（路径）</b>-UiPath股价在盘前交易中下跌1.5%，尽管这家“软件机器人”提供商的季度业绩超出了华尔街的预期。</blockquote></p><p> <b>Yum Brands(YUM)</b> – The parent of KFC, Pizza Hut and Taco Bell was upgraded to “overweight” from “neutral” at Atlantic Equities, which sees the possibility of rising returns from the restaurant chain and calls Yum its favored name in the quick-service restaurant category. Yum rose 1% in the premarket.</p><p><blockquote><b>百胜餐饮集团(YUM)</b>-大西洋股票(Atlantic Equities)将肯德基、必胜客和塔可钟(Taco Bell)的母公司评级从“中性”上调至“跑赢大盘”，该公司认为这家连锁餐厅的回报可能会上升，而评级百胜是其在快餐店类别中最受欢迎的名称。百胜餐饮盘前上涨1%。</blockquote></p><p> <b>Pear Therapeutics(PEAR)</b> – Pear Therapeutics shares soared 30% in premarket trading.Prescription digital therapeutics company Pear Therapeutics began trading on Nasdaq Monday after wrapping up its merger with special-purpose acquisition company Thimble Point Acquisition Corp. last week.</p><p><blockquote><b>梨疗法(PEAR)</b>-Pear Therapeutics股价在盘前交易中飙升30%。处方数字治疗公司Pear Therapeutics在上周完成与特殊目的收购公司Thimble Point Acquisition Corp.的合并后，周一开始在纳斯达克交易。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Thursday<blockquote>周四美国市场开盘前的营收</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Thursday<blockquote>周四美国市场开盘前的营收</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-09 21:35</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>U.S. stock-index futures hold solid losses after initial jobless claims come in at 184,000.</p><p><blockquote>首次申请失业救济人数达到184,000人后，美国股指期货继续下跌。</blockquote></p><p> At 8:34 a.m. ET, Dow e-minis were down 168 points, or 0.47%, S&P 500 e-minis were down 21 points, or 0.45%, and Nasdaq 100 e-minis were down 80.5 points, or 0.49%.</p><p><blockquote>截至美国东部时间上午8:34，道指e-minis下跌168点，跌幅0.47%，标普500 e-minis下跌21点，跌幅0.45%，纳斯达克100 e-minis下跌80.5点，跌幅0.49%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/e48b5d3abdc91abde117585acac09b40\" tg-width=\"401\" tg-height=\"184\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Weekly jobless claims reached tumbled last week, reaching a fresh 52-year low as the U.S. jobs market climbs out of its pandemic-era hole, the Labor Department reported Thursday.</p><p><blockquote>美国劳工部周四报告称，随着美国就业市场走出大流行时期的困境，上周每周申请失业救济人数大幅下降，创下52年来的新低。</blockquote></p><p> Initial filings for unemployment insurance totaled 184,000 for the week ended Dec. 4, the lowest going back to Sept. 6, 1969, which saw 182,000.</p><p><blockquote>截至12月4日当周，首次申请失业保险的人数为184,000人，是自1969年9月6日（182,000人）以来的最低水平。</blockquote></p><p> Initial claims for unemployment insurance were expected to total 211,000 for the week ended Dec. 4, according to a Dow Jones economist survey.</p><p><blockquote>根据道琼斯经济学家的调查，截至12月4日当周，首次申请失业保险的人数预计为21.1万人。</blockquote></p><p> Meanwhile, a deal to avert U.S. debt default and raise the federal government's $28.9 trillion debt limit will be tested on Thursday in the Senate when the full chamber votes on whether to approve the measure.</p><p><blockquote>与此同时，一项避免美国债务违约并提高联邦政府28.9万亿美元债务上限的协议将于周四在参议院接受测试，届时众议院全体成员将就是否批准该措施进行投票。</blockquote></p><p> <b>Stocks making the biggest moves premarket: </b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <b>GameStop(GME)</b> – GameStop shares slid 5.6% in premarket trading after the videogame retailer posted a wider loss compared with a year earlier and also disclosed an August subpoena from the SEC involving the trading of its shares.</p><p><blockquote><b>游戏驿站(GME)</b>-游戏驿站股价在盘前交易中下跌5.6%，此前这家视频游戏零售商公布了与去年同期相比更大的亏损，并披露了美国证券交易委员会8月份发出的涉及其股票交易的传票。</blockquote></p><p> <b>Lucid Group(LCID)</b> – Lucid shares tumbled 6.5% in the premarket after the electric vehicle maker announced a $1.75 billion offering of convertible senior notes.</p><p><blockquote><b>Lucid集团(LCID)</b>–电动汽车制造商Lucid宣布发行17.5亿美元的可转换优先票据后，该公司股价在盘前下跌6.5%。</blockquote></p><p> <b>FuboTV(FUBO) </b>– The video streaming company was rated “overweight” in new coverage at J.P. Morgan Securities, based on Fubo’s sports-centered offerings as a differentiating factor. The stock jumped 2.8% in premarket action.</p><p><blockquote><b>FuboTV（富博）</b>-该视频流媒体公司在摩根大通证券的新报道中被评为“跑赢大盘”，这是基于富博以体育为中心的产品作为差异化因素。该股在盘前上涨2.8%。</blockquote></p><p> <b>CVS Health(CVS)</b> – The drug store operator issued new guidance ahead of its investor day, saying it expects a 2022 adjusted profit of $8.10 to $8.30 per share compared with an $8.24 consensus estimate and better-than-expected revenue. CVS also raised its 2021 outlook, and the shares rallied 2.6% in the premarket.</p><p><blockquote><b>CVS健康(CVS)</b>–这家药店运营商在投资者日之前发布了新的指引，称预计2022年调整后每股利润为8.10美元至8.30美元，而市场普遍预期为8.24美元，收入好于预期。CVS还上调了2021年展望，股价盘前上涨2.6%。</blockquote></p><p> <b>Hormel(HRL)</b> – The food producer beat estimates by a penny with quarterly earnings of 51 cents per share, and revenue that also topped Wall Street forecasts. Hormel saw double-digit growth across all of its business segments, and shares rose 1% in premarket trading.</p><p><blockquote><b>荷美尔(HRL)</b>–这家食品生产商的季度收益为每股51美分，超出预期1美分，收入也超出了华尔街的预期。荷美尔所有业务部门均实现两位数增长，股价在盘前交易中上涨1%。</blockquote></p><p> <b>RH(RH)</b> – The company formerly known as Restoration Hardware reported adjusted quarterly earnings of $7.03 per share, 40 cents above estimates, while the luxury home furnishings retailer’s revenue beat forecasts. RH also lifted the low end of its revenue outlook. RH surged 11% in premarket action.</p><p><blockquote><b>相对湿度（相对湿度）</b>-该公司前身为Restoration Hardware，报告调整后季度收益为每股7.03美元，比预期高出40美分，而这家豪华家居用品零售商的收入超出预期。RH还上调了收入预期的下限。RH在盘前交易中飙升11%。</blockquote></p><p> <b>Rent The Runway(RENT)</b> – Rent The Runway tumbled 8.2% in the premarket after the fashion rental company posted a loss that was wider than a year ago and reported subscriber numbers that have not yet returned to pre-pandemic levels. Sales did surge 66% over the same quarter a year ago.</p><p><blockquote><b>租用跑道（Rent）</b>–Rent The Runway在盘前下跌8.2%，此前这家时尚租赁公司公布的亏损幅度超过一年前，且订户数量尚未恢复到大流行前的水平。销售额确实比去年同期猛增了66%。</blockquote></p><p> <b>Apple(AAPL)</b> – Apple won an appeals court decision that delays changes to its App Store. An earlier ruling had ordered Apple to allow developers to offer payment alternatives outside of the App Store, stemming from its legal dispute with “Fortnite” developer Epic Games. Separately, Apple is closing in on a $3 trillion valuation, which will be achieved when the share price hits $182.86.</p><p><blockquote><b>苹果(AAPL)</b>-苹果赢得了上诉法院的裁决，推迟了对其应用商店的更改。早些时候的一项裁决命令苹果允许开发者在App Store之外提供支付替代方案，源于其与《堡垒之夜》开发商Epic Games的法律纠纷。另外，苹果的估值接近3万亿美元，这一估值将在股价达到182.86美元时实现。</blockquote></p><p> <b>Amazon(AMZN)</b> – Italy's antitrust said on Thursday it had fined e-commerce giant Amazon 1.13 billion euros ($1.28 billion) for alleged abuse of market dominance.</p><p><blockquote><b>亚马逊(AMZN)</b>-意大利反垄断机构周四表示，已对电商巨头亚马逊处以11.3亿欧元（12.8亿美元）的罚款，原因是其涉嫌滥用市场支配地位。</blockquote></p><p> <b>AstraZeneca(AZN)</b> – The drug maker’s Covid-19 antibody treatment won FDA approval for patients who cannot achieve adequate protection from vaccination.</p><p><blockquote><b>阿斯利康(AZN)</b>-该制药商的Covid-19抗体治疗获得FDA批准，用于无法通过疫苗接种获得足够保护的患者。</blockquote></p><p> <b>LabCorp(LH)</b> – The medical lab operator announced a number of steps to enhance shareholder value, including the initiation of a dividend in the second quarter of 2022 and the authorization of a $2.5 billion share repurchase program.</p><p><blockquote><b>LabCorp(LH)</b>–这家医学实验室运营商宣布了一系列提高股东价值的措施，包括在2022年第二季度启动股息以及授权25亿美元的股票回购计划。</blockquote></p><p> <b>UiPath(PATH)</b> – UiPath stock dropped 1.5% in premarket trading even as the “software robots” provider’s quarterly results topped Wall Street expectations.</p><p><blockquote><b>UiPath（路径）</b>-UiPath股价在盘前交易中下跌1.5%，尽管这家“软件机器人”提供商的季度业绩超出了华尔街的预期。</blockquote></p><p> <b>Yum Brands(YUM)</b> – The parent of KFC, Pizza Hut and Taco Bell was upgraded to “overweight” from “neutral” at Atlantic Equities, which sees the possibility of rising returns from the restaurant chain and calls Yum its favored name in the quick-service restaurant category. Yum rose 1% in the premarket.</p><p><blockquote><b>百胜餐饮集团(YUM)</b>-大西洋股票(Atlantic Equities)将肯德基、必胜客和塔可钟(Taco Bell)的母公司评级从“中性”上调至“跑赢大盘”，该公司认为这家连锁餐厅的回报可能会上升，而评级百胜是其在快餐店类别中最受欢迎的名称。百胜餐饮盘前上涨1%。</blockquote></p><p> <b>Pear Therapeutics(PEAR)</b> – Pear Therapeutics shares soared 30% in premarket trading.Prescription digital therapeutics company Pear Therapeutics began trading on Nasdaq Monday after wrapping up its merger with special-purpose acquisition company Thimble Point Acquisition Corp. last week.</p><p><blockquote><b>梨疗法(PEAR)</b>-Pear Therapeutics股价在盘前交易中飙升30%。处方数字治疗公司Pear Therapeutics在上周完成与特殊目的收购公司Thimble Point Acquisition Corp.的合并后，周一开始在纳斯达克交易。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LCID":"Lucid Group Inc","FUBO":"fuboTV Inc.","YUM":"Yum Brands",".DJI":"道琼斯","PEAR":"Pear Therapeutics",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite","RENT":"Rent the Runway, Inc.","LH":"徕博科","HRL":"荷美尔","AAPL":"苹果","AMZN":"亚马逊","AZN":"阿斯利康","RH":"RH","GME":"游戏驿站","PATH":"UiPath","CVS":"西维斯健康"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163175495","content_text":"U.S. stock-index futures hold solid losses after initial jobless claims come in at 184,000.\nAt 8:34 a.m. ET, Dow e-minis were down 168 points, or 0.47%, S&P 500 e-minis were down 21 points, or 0.45%, and Nasdaq 100 e-minis were down 80.5 points, or 0.49%.\n\nWeekly jobless claims reached tumbled last week, reaching a fresh 52-year low as the U.S. jobs market climbs out of its pandemic-era hole, the Labor Department reported Thursday.\nInitial filings for unemployment insurance totaled 184,000 for the week ended Dec. 4, the lowest going back to Sept. 6, 1969, which saw 182,000.\nInitial claims for unemployment insurance were expected to total 211,000 for the week ended Dec. 4, according to a Dow Jones economist survey.\nMeanwhile, a deal to avert U.S. debt default and raise the federal government's $28.9 trillion debt limit will be tested on Thursday in the Senate when the full chamber votes on whether to approve the measure.\nStocks making the biggest moves premarket: \nGameStop(GME) – GameStop shares slid 5.6% in premarket trading after the videogame retailer posted a wider loss compared with a year earlier and also disclosed an August subpoena from the SEC involving the trading of its shares.\nLucid Group(LCID) – Lucid shares tumbled 6.5% in the premarket after the electric vehicle maker announced a $1.75 billion offering of convertible senior notes.\nFuboTV(FUBO) – The video streaming company was rated “overweight” in new coverage at J.P. Morgan Securities, based on Fubo’s sports-centered offerings as a differentiating factor. The stock jumped 2.8% in premarket action.\nCVS Health(CVS) – The drug store operator issued new guidance ahead of its investor day, saying it expects a 2022 adjusted profit of $8.10 to $8.30 per share compared with an $8.24 consensus estimate and better-than-expected revenue. CVS also raised its 2021 outlook, and the shares rallied 2.6% in the premarket.\nHormel(HRL) – The food producer beat estimates by a penny with quarterly earnings of 51 cents per share, and revenue that also topped Wall Street forecasts. Hormel saw double-digit growth across all of its business segments, and shares rose 1% in premarket trading.\nRH(RH) – The company formerly known as Restoration Hardware reported adjusted quarterly earnings of $7.03 per share, 40 cents above estimates, while the luxury home furnishings retailer’s revenue beat forecasts. RH also lifted the low end of its revenue outlook. RH surged 11% in premarket action.\nRent The Runway(RENT) – Rent The Runway tumbled 8.2% in the premarket after the fashion rental company posted a loss that was wider than a year ago and reported subscriber numbers that have not yet returned to pre-pandemic levels. Sales did surge 66% over the same quarter a year ago.\nApple(AAPL) – Apple won an appeals court decision that delays changes to its App Store. An earlier ruling had ordered Apple to allow developers to offer payment alternatives outside of the App Store, stemming from its legal dispute with “Fortnite” developer Epic Games. Separately, Apple is closing in on a $3 trillion valuation, which will be achieved when the share price hits $182.86.\nAmazon(AMZN) – Italy's antitrust said on Thursday it had fined e-commerce giant Amazon 1.13 billion euros ($1.28 billion) for alleged abuse of market dominance.\nAstraZeneca(AZN) – The drug maker’s Covid-19 antibody treatment won FDA approval for patients who cannot achieve adequate protection from vaccination.\nLabCorp(LH) – The medical lab operator announced a number of steps to enhance shareholder value, including the initiation of a dividend in the second quarter of 2022 and the authorization of a $2.5 billion share repurchase program.\nUiPath(PATH) – UiPath stock dropped 1.5% in premarket trading even as the “software robots” provider’s quarterly results topped Wall Street expectations.\nYum Brands(YUM) – The parent of KFC, Pizza Hut and Taco Bell was upgraded to “overweight” from “neutral” at Atlantic Equities, which sees the possibility of rising returns from the restaurant chain and calls Yum its favored name in the quick-service restaurant category. Yum rose 1% in the premarket.\nPear Therapeutics(PEAR) – Pear Therapeutics shares soared 30% in premarket trading.Prescription digital therapeutics company Pear Therapeutics began trading on Nasdaq Monday after wrapping up its merger with special-purpose acquisition company Thimble Point Acquisition Corp. last week.","news_type":1,"symbols_score_info":{"LCID":0.9,"CVS":0.9,"RH":0.9,"PATH":0.9,"FUBO":0.9,"AAPL":0.9,"YMmain":0.9,"PEAR":0.9,"RENT":0.9,"LH":0.9,"HRL":0.9,"GME":0.9,"AMZN":0.9,".DJI":0.9,".IXIC":0.9,"YUM":0.9,".SPX":0.9,"AZN":0.9,"ESmain":0.9,"NQmain":0.9}},"isVote":1,"tweetType":1,"viewCount":2810,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608592730,"gmtCreate":1638755825406,"gmtModify":1638755825557,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581839766583119","idStr":"3581839766583119"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608592730","repostId":"2189572015","repostType":4,"isVote":1,"tweetType":1,"viewCount":4351,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601142311,"gmtCreate":1638501717685,"gmtModify":1638501717799,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581839766583119","idStr":"3581839766583119"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601142311","repostId":"1153040082","repostType":4,"isVote":1,"tweetType":1,"viewCount":2317,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609263946,"gmtCreate":1638286459717,"gmtModify":1638286459821,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581839766583119","idStr":"3581839766583119"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/609263946","repostId":"2187817235","repostType":4,"isVote":1,"tweetType":1,"viewCount":3046,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609269803,"gmtCreate":1638286396410,"gmtModify":1638286402364,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581839766583119","idStr":"3581839766583119"},"themes":[],"htmlText":"Like ","listText":"Like ","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609269803","repostId":"2187817235","repostType":4,"isVote":1,"tweetType":1,"viewCount":2228,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600158524,"gmtCreate":1638102158340,"gmtModify":1638102158488,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581839766583119","idStr":"3581839766583119"},"themes":[],"htmlText":"Loke","listText":"Loke","text":"Loke","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600158524","repostId":"2186432895","repostType":4,"isVote":1,"tweetType":1,"viewCount":3686,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874549255,"gmtCreate":1637804661725,"gmtModify":1637804661831,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581839766583119","idStr":"3581839766583119"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/874549255","repostId":"2186363038","repostType":4,"isVote":1,"tweetType":1,"viewCount":3130,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874635908,"gmtCreate":1637765401002,"gmtModify":1637765401109,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581839766583119","idStr":"3581839766583119"},"themes":[],"htmlText":"Like ","listText":"Like ","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/874635908","repostId":"1182883462","repostType":4,"repost":{"id":"1182883462","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1637765117,"share":"https://www.laohu8.com/m/news/1182883462?lang=zh_CN&edition=full","pubTime":"2021-11-24 22:45","market":"us","language":"en","title":"Outlook Shares Plunges After Raising $50M Via Equity Offering Issued At 20% Discount<blockquote>Outlook以20%折扣发行股票筹集5000万美元后股价暴跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1182883462","media":"Benzinga","summary":"Outlook shares plunged more than 22% in early trading.Outlook Therapeutics Inc has increased the siz","content":"<p>Outlook shares plunged more than 22% in early trading.<img src=\"https://static.tigerbbs.com/400d88d0cf7a467f2553f97a56faba44\" tg-width=\"868\" tg-height=\"610\" referrerpolicy=\"no-referrer\"><b>Outlook Therapeutics Inc</b> has increased the size of the previously announced public offering to 40 million shares at $1.25 per share, for gross proceeds of $50 million. The offer price represents a discount of almost 20% from the last close price of $1.56 on Tuesday.</p><p><blockquote>Outlook股价早盘暴跌逾22%。<b>展望治疗公司</b>已将之前宣布的公开发行规模增加至4000万股，每股1.25美元，总收益为5000万美元。此次要约价格较周二最后收盘价1.56美元有近20%的折扣。</blockquote></p><p> Previously, the Company offered 8 million shares at $1.25 per share.</p><p><blockquote>此前，该公司以每股1.25美元的价格发行了800万股股票。</blockquote></p><p> The offering will close by November 29.</p><p><blockquote>此次发行将于11月29日结束。</blockquote></p><p> H.C. Wainwright & Co. is acting as the sole book-running manager for the offering.</p><p><blockquote>H.C.Wainwright&Co.担任此次发行的唯一账簿管理人。</blockquote></p><p> GMS Ventures and Investments, an affiliate of Outlook Therapeutics' largest stockholder and strategic partner, BioLexis Pte. Ltd., has indicated an interest in purchasing directly or through an affiliate up to $20 million of the shares in the offering.</p><p><blockquote>GMS Ventures and Investments是Outlook Therapeutics最大股东和战略合作伙伴BioLexis Pte.的子公司。Ltd.已表示有兴趣直接或通过附属公司购买最多2000万美元的此次发行股票。</blockquote></p><p> Outlook Therapeutics will use the net proceeds for working capital and general corporate purposes, including supporting its ONS-5010 development program.</p><p><blockquote>Outlook Therapeutics将把净收益用于营运资金和一般公司用途，包括支持其ONS-5010开发计划。</blockquote></p><p> Recently, Outlook presented pivotal safety and efficacy data from the Phase 3 NORSE TWO trial for ONS-5010 at the Retinal Subspecialty Day, AAO 2021 Annual Conference.</p><p><blockquote>最近，Outlook在AAO 2021年年会视网膜亚专科日上展示了ONS-5010 3期NORSE TWO试验的关键安全性和有效性数据。</blockquote></p><p> ONS-5010 is an investigational ophthalmic formulation of bevacizumab for use in wet age-related macular degeneration (wet AMD) and other retinal indications,</p><p><blockquote>ONS-5010是贝伐珠单抗的一种在研眼科制剂，用于湿性年龄相关性黄斑变性（湿性AMD）和其他视网膜适应症，</blockquote></p><p> Outlook Therapeutics plans to submit a marketing application in Q1 of 2022.</p><p><blockquote>Outlook Therapeutics计划于2022年第一季度提交营销申请。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Outlook Shares Plunges After Raising $50M Via Equity Offering Issued At 20% Discount<blockquote>Outlook以20%折扣发行股票筹集5000万美元后股价暴跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOutlook Shares Plunges After Raising $50M Via Equity Offering Issued At 20% Discount<blockquote>Outlook以20%折扣发行股票筹集5000万美元后股价暴跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-11-24 22:45</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p>Outlook shares plunged more than 22% in early trading.<img src=\"https://static.tigerbbs.com/400d88d0cf7a467f2553f97a56faba44\" tg-width=\"868\" tg-height=\"610\" referrerpolicy=\"no-referrer\"><b>Outlook Therapeutics Inc</b> has increased the size of the previously announced public offering to 40 million shares at $1.25 per share, for gross proceeds of $50 million. The offer price represents a discount of almost 20% from the last close price of $1.56 on Tuesday.</p><p><blockquote>Outlook股价早盘暴跌逾22%。<b>展望治疗公司</b>已将之前宣布的公开发行规模增加至4000万股，每股1.25美元，总收益为5000万美元。此次要约价格较周二最后收盘价1.56美元有近20%的折扣。</blockquote></p><p> Previously, the Company offered 8 million shares at $1.25 per share.</p><p><blockquote>此前，该公司以每股1.25美元的价格发行了800万股股票。</blockquote></p><p> The offering will close by November 29.</p><p><blockquote>此次发行将于11月29日结束。</blockquote></p><p> H.C. Wainwright & Co. is acting as the sole book-running manager for the offering.</p><p><blockquote>H.C.Wainwright&Co.担任此次发行的唯一账簿管理人。</blockquote></p><p> GMS Ventures and Investments, an affiliate of Outlook Therapeutics' largest stockholder and strategic partner, BioLexis Pte. Ltd., has indicated an interest in purchasing directly or through an affiliate up to $20 million of the shares in the offering.</p><p><blockquote>GMS Ventures and Investments是Outlook Therapeutics最大股东和战略合作伙伴BioLexis Pte.的子公司。Ltd.已表示有兴趣直接或通过附属公司购买最多2000万美元的此次发行股票。</blockquote></p><p> Outlook Therapeutics will use the net proceeds for working capital and general corporate purposes, including supporting its ONS-5010 development program.</p><p><blockquote>Outlook Therapeutics将把净收益用于营运资金和一般公司用途，包括支持其ONS-5010开发计划。</blockquote></p><p> Recently, Outlook presented pivotal safety and efficacy data from the Phase 3 NORSE TWO trial for ONS-5010 at the Retinal Subspecialty Day, AAO 2021 Annual Conference.</p><p><blockquote>最近，Outlook在AAO 2021年年会视网膜亚专科日上展示了ONS-5010 3期NORSE TWO试验的关键安全性和有效性数据。</blockquote></p><p> ONS-5010 is an investigational ophthalmic formulation of bevacizumab for use in wet age-related macular degeneration (wet AMD) and other retinal indications,</p><p><blockquote>ONS-5010是贝伐珠单抗的一种在研眼科制剂，用于湿性年龄相关性黄斑变性（湿性AMD）和其他视网膜适应症，</blockquote></p><p> Outlook Therapeutics plans to submit a marketing application in Q1 of 2022.</p><p><blockquote>Outlook Therapeutics计划于2022年第一季度提交营销申请。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OTLK":"Outlook Therapeutics, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1182883462","content_text":"Outlook shares plunged more than 22% in early trading.Outlook Therapeutics Inc has increased the size of the previously announced public offering to 40 million shares at $1.25 per share, for gross proceeds of $50 million. The offer price represents a discount of almost 20% from the last close price of $1.56 on Tuesday.\nPreviously, the Company offered 8 million shares at $1.25 per share.\nThe offering will close by November 29.\nH.C. Wainwright & Co. is acting as the sole book-running manager for the offering.\nGMS Ventures and Investments, an affiliate of Outlook Therapeutics' largest stockholder and strategic partner, BioLexis Pte. Ltd., has indicated an interest in purchasing directly or through an affiliate up to $20 million of the shares in the offering.\nOutlook Therapeutics will use the net proceeds for working capital and general corporate purposes, including supporting its ONS-5010 development program.\nRecently, Outlook presented pivotal safety and efficacy data from the Phase 3 NORSE TWO trial for ONS-5010 at the Retinal Subspecialty Day, AAO 2021 Annual Conference.\nONS-5010 is an investigational ophthalmic formulation of bevacizumab for use in wet age-related macular degeneration (wet AMD) and other retinal indications,\nOutlook Therapeutics plans to submit a marketing application in Q1 of 2022.","news_type":1,"symbols_score_info":{"OTLK":0.9}},"isVote":1,"tweetType":1,"viewCount":3409,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875858515,"gmtCreate":1637634759931,"gmtModify":1637634760043,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581839766583119","idStr":"3581839766583119"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875858515","repostId":"2185306806","repostType":4,"isVote":1,"tweetType":1,"viewCount":3170,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872696497,"gmtCreate":1637497892937,"gmtModify":1637497893038,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581839766583119","idStr":"3581839766583119"},"themes":[],"htmlText":"Loke","listText":"Loke","text":"Loke","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872696497","repostId":"1193739210","repostType":4,"repost":{"id":"1193739210","kind":"news","pubTimestamp":1637457862,"share":"https://www.laohu8.com/m/news/1193739210?lang=zh_CN&edition=full","pubTime":"2021-11-21 09:24","market":"us","language":"en","title":"Does Sono Group Have a Breakthrough Innovation That Could Put “Range Anxiety” to Bed?<blockquote>索诺集团是否有突破性创新可以消除“里程焦虑”？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1193739210","media":"Investorplace","summary":"In a blink-and-you-miss-it moment this week, one of the most interestingelectric vehicle (EV) startu","content":"<p><div> In a blink-and-you-miss-it moment this week, one of the most interestingelectric vehicle (EV) startupsin the worldwent publicthrough a super successful initial public offering (IPO). That company is ...</p><p><blockquote><div>本周，世界上最有趣的电动汽车(EV)初创公司之一通过超级成功的首次公开募股(IPO)上市。那家公司是...</div></blockquote></p><p> <a href=\"https://investorplace.com/hypergrowthinvesting/2021/11/does-sono-group-have-a-breakthrough-innovation-that-could-put-range-anxiety-to-bed/\">网页链接</a> </div> </p><p><blockquote><a href=\"https://investorplace.com/hypergrowthinvesting/2021/11/does-sono-group-have-a-breakthrough-innovation-that-could-put-range-anxiety-to-bed/\">网页连接</a></blockquote></p><p></p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Does Sono Group Have a Breakthrough Innovation That Could Put “Range Anxiety” to Bed?<blockquote>索诺集团是否有突破性创新可以消除“里程焦虑”？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDoes Sono Group Have a Breakthrough Innovation That Could Put “Range Anxiety” to Bed?<blockquote>索诺集团是否有突破性创新可以消除“里程焦虑”？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Investorplace</strong><span class=\"h-time small\">2021-11-21 09:24</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> In a blink-and-you-miss-it moment this week, one of the most interestingelectric vehicle (EV) startupsin the worldwent publicthrough a super successful initial public offering (IPO). That company is ...</p><p><blockquote><div>本周，世界上最有趣的电动汽车(EV)初创公司之一通过超级成功的首次公开募股(IPO)上市。那家公司是...</div></blockquote></p><p> <a href=\"https://investorplace.com/hypergrowthinvesting/2021/11/does-sono-group-have-a-breakthrough-innovation-that-could-put-range-anxiety-to-bed/\">网页链接</a> </div> </p><p><blockquote><a href=\"https://investorplace.com/hypergrowthinvesting/2021/11/does-sono-group-have-a-breakthrough-innovation-that-could-put-range-anxiety-to-bed/\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://investorplace.com/hypergrowthinvesting/2021/11/does-sono-group-have-a-breakthrough-innovation-that-could-put-range-anxiety-to-bed/\">Investorplace</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SEV":"Aptera Motors"},"source_url":"https://investorplace.com/hypergrowthinvesting/2021/11/does-sono-group-have-a-breakthrough-innovation-that-could-put-range-anxiety-to-bed/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1193739210","content_text":"In a blink-and-you-miss-it moment this week, one of the most interestingelectric vehicle (EV) startupsin the worldwent publicthrough a super successful initial public offering (IPO).\nThat company is the Germany-based Sono Group(NASDAQ:SEV) – a small EV company that’s unlike any other electric vehicle firm on the planet. This isn’t the next Tesla(NASDAQ:TSLA),nor is it the next Lucid Group(NASDAQ:LCID) or Rivian(NASDAQ:RIVN)… and that’s by design.\nBecause, while all those EV makers are making plug-in electric vehicles, Sono is making the world’s firstsolar electric vehicle, or “SEV.”\nSoaring 150%-plus from its $15 IPO price Wednesday, investors have sat up to take notice of this company that is helmed by a CEO barely out of university.\nIndeed, at age 26, Sono founder Laurin Hahn cuts a very different image than your typical CEO. Hahn’s an environmentalist and idealist at heart, which is why Sono’s goal isn’t just to sell cars, but to “implement an innovative CO2-neutral mobility concept.” Out of that vision comes the Sion– an understated, no-frills attempt at designing an effective solar EV for the masses.\nAnd unlike the glossy, leather-clad premium electric vehicles dominating most conversations around EVs, the Sion actually feels like a vehicle designed to put the world on the right path toward net-zero carbon emissions.\nTo ensure its vision aligned with the needs of everyday drivers, the company’s signature vehicle – the Sion – had its users in mind from the very beginning. Everything from the color and upholstery of the car to the voltage and resulting range of the battery was voted on by a community of 15,000.\nAs for its look, the Sion essentially replaces the exterior aluminum and paint on an electric car with 248 flexible solar modules that are perfectly adapted to the shape of the vehicle.\nThe car looks, drives, and acts just like any other mass-market EV. But as it drives, it charges itself through these solar cells. There’s a still a battery at the core of the vehicle, but it doesn’t rely on being plugged in – the battery can be recharged by simply leaving it out in the sun.\nThe huge value-add here, of course, is solving so-called EV “range anxiety,” or the fear that EVs won’t be able to drive you as far as you need to go.\nTo-date, such fears have proven very legitimate. After all, your typical EV today fetches around 250 miles of driving range. Your average gas car can travel up to 400 miles per tank. So, yes, EVs have historically been limiting in terms of how far they can travel.\nSono Motors believes that its solar EV tech will fix this issue. And while it is a very innovative solution that we find super interesting, there’s just one small issue:It doesn’t actually solve the “range anxiety” problem.\nSono’s claim is that its solar cells collectively add about 70 miles of driving range to its Sion EV, which has a built-in driving range of 190 miles. Add it up, and even with these solar panels, the Sion still gets less than 300 miles of real-time driving range – much less than the 400 miles a gas-powered car fetches per tank.\nBut solar technology is not static –it’s very dynamic. And right now, scientists across the globe are working on multiple solar technology breakthroughs to dramatically improve the performance of solar cells. One such promising breakthrough is the inclusion of perovskites in solar cells. Perovskites are a very flexible material, and therefore, could be included in Sono’s solar mobility tech to significantly improve the performance of these SEVs.\nIn other words, while solar electric vehicles are cool, the underlying solar cell technology here is still many years away from being robust enough to actually solve EV range anxiety fears.\nThat’s the bad news.\nThe good news, though, is that we don’t evenneedsolar electric vehicles to solve range anxiety…\nBecause there is another breakthrough battery technology being pioneered today, which is ready to add not just 70 or 80 miles of driving range to an EV – but potentially thousands of miles of driving range to an EV, thereby allowing electric cars to travel as much as 10X as far as gas-powered cars on a single charge.\nThese batteries are the future and will forever solve the EV “range anxiety” problem.\nIt’s simple, really… With them, EVs will last forever.\nThe technology behind these forever batteries is exceptionally complex – so complex, in fact, that no one has been able to make one big enough to power an electric car yet.\nBut that’s changing right now, as some companies in this space have – for the first time ever – built small-scale “forever batteries” that are working. Now, all these companies have to do is scale these batteries and make them bigger.\nMake no mistake. They’re going to do just that. And the companies behind this forever battery technology will turn into titans of the EV industry.\nNot to mention,their stocks will score shareholders enormous returns.","news_type":1,"symbols_score_info":{"SEV":0.9}},"isVote":1,"tweetType":1,"viewCount":2247,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872696842,"gmtCreate":1637497842731,"gmtModify":1637497842833,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581839766583119","idStr":"3581839766583119"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/872696842","repostId":"1156888846","repostType":4,"repost":{"id":"1156888846","kind":"news","pubTimestamp":1637465976,"share":"https://www.laohu8.com/m/news/1156888846?lang=zh_CN&edition=full","pubTime":"2021-11-21 11:39","market":"us","language":"en","title":"Why Ford Is Terminating Its Joint EV Development Plan With Rivian?<blockquote>为什么福特终止与Rivian的联合电动汽车开发计划？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1156888846","media":"Benzinga","summary":"Ford Motor Company, which is one of the early backers of EV startup Rivian Automotive, Inc., is shel","content":"<p><div> Ford Motor Company, which is one of the early backers of EV startup Rivian Automotive, Inc., is shelving its plan to develop an EV with the latter altogether. What Happened:As Ford steps on the gas on...</p><p><blockquote><div>福特汽车公司是电动汽车初创公司Rivian汽车公司的早期支持者之一，该公司正在完全搁置与后者开发电动汽车的计划。发生了什么：当福特踩下油门时...</div></blockquote></p><p> <a href=\"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian\">网页链接</a> </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Ford Is Terminating Its Joint EV Development Plan With Rivian?<blockquote>为什么福特终止与Rivian的联合电动汽车开发计划？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Ford Is Terminating Its Joint EV Development Plan With Rivian?<blockquote>为什么福特终止与Rivian的联合电动汽车开发计划？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-11-21 11:39</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Ford Motor Company, which is one of the early backers of EV startup Rivian Automotive, Inc., is shelving its plan to develop an EV with the latter altogether. What Happened:As Ford steps on the gas on...</p><p><blockquote><div>福特汽车公司是电动汽车初创公司Rivian汽车公司的早期支持者之一，该公司正在完全搁置与后者开发电动汽车的计划。发生了什么：当福特踩下油门时...</div></blockquote></p><p> <a href=\"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian\">网页链接</a> </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian\">Benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RIVN":"Rivian Automotive, Inc.","F":"福特汽车"},"source_url":"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156888846","content_text":"Ford Motor Company, which is one of the early backers of EV startup Rivian Automotive, Inc., is shelving its plan to develop an EV with the latter altogether.\nWhat Happened:As Ford steps on the gas on its EV transition, the Detroit-based automaker has decided to abandon it plans to jointly develop an EV with Rivian, CEO Jim Farley said in an interview with Automotive News.\nFarley said Ford expects to produce 600,000 vehicles per year by the end of 2023.\nWhen Ford initially invested $500 million in Rivian in 2019, it envisaged developing a Ford branded EV that will come with Rivian's skateboard powertrain. In early 2020, the companies said they are shelving the plans for a Lincoln-branded EV but would go ahead with an alternative vehicle based on Rivian technology.\nThe Ford CEO suggested in the interview that the company is now increasingly confident in competing in the EV space by itself. Another handicap that forced the going-solo decision was the complexities involved in integrating the hardware and software together.\nWhy It's Important:Rivian shares debuted on Wall Street on Nov. 10 following aninitial public offeringat a bumper valuation of over $100 billion. The company's strong debut and the subsequent run up in shares have raised eyebrows over its valuation which has taken it past the market capitalization of legacy U.S. automakers, including Ford.\nRivian's product pipeline consists of RIT, an EV pickup truck, which it began delivering to customers in September. As of Oct. 30, the company produced 180 R1Ts and delivered 156 R1Ts, with the bulk of them going to the company's employees.\nThe company noted that at the end of October, it had preorders of about 55,400 R1Ts and R1Ss. It expects to fill the preorder backlog by the end of 2023.\nFord, for its part, has doubled on itsEV strategyand invested big dollars into its transition toward EVs.\n\"We respect Rivian and have had extensive exploratory discussions with them, however, both sides have agreed not to pursue any kind of joint vehicle development or platform sharing,\" Ford said in an emailed statement to media.\nRivian, meanwhile, confirmed that it is a mutual decision to focus on each of their own projects and deliveries, given Ford has scaled its own EV strategy and demand for Rivian vehicles has grown.\n\"Our relationship with Ford is an important part of our journey, and Ford remains an investor and ally on our shared path to an electrified future\" a Rivian spokesperson said.\nRivian closed Friday's session up 4.23% at $128.60, while Ford closed down 0.87% at $19.39.","news_type":1,"symbols_score_info":{"F":0.9,"RIVN":0.9}},"isVote":1,"tweetType":1,"viewCount":688,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872945229,"gmtCreate":1637407178442,"gmtModify":1637407178580,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581839766583119","idStr":"3581839766583119"},"themes":[],"htmlText":"Like ","listText":"Like ","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/872945229","repostId":"2184842262","repostType":4,"isVote":1,"tweetType":1,"viewCount":494,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876562855,"gmtCreate":1637332895262,"gmtModify":1637332895704,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581839766583119","idStr":"3581839766583119"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876562855","repostId":"876397745","repostType":1,"repost":{"id":876397745,"gmtCreate":1637258452030,"gmtModify":1708926202010,"author":{"id":"3545995761422355","authorId":"3545995761422355","name":"不二说价值","avatar":"https://static.tigerbbs.com/56fa489972246881ba23cfecebfd4c45","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3545995761422355","idStr":"3545995761422355"},"themes":[],"title":"哔哩哔哩（B站）股票财报后两天暴跌30%，小破站会重蹈牛夫人爱奇艺的覆辙么？","htmlText":"\n \n \n 📢请关注我的youtube频道：不二说价值。以确保收看所有完整的节目。📢 我会持续对优质公司进行估价，帮助虎友做出更合理的交易决策。欢迎评论留下自己想估价的股票，热门留言我会优先估价。✅配合视频站，我的空间站专属内容大幅增加，每月还会有独家现金福利哦！具体请看：<a href=\"https://laohu8.com/TW/140843402\" target=\"_blank\">十万刀空间站独家内容和丰富福利介绍</a><a target=\"_blank\" href=\"https://laohu8.com/S/BILI\">$哔哩哔哩(BILI)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/IQ\">$爱奇艺(IQ)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/NFLX\">$Netflix, Inc.(NFLX)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/BIDU\">$百度(BIDU)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/GOOG\">$谷歌(GOOG)$</a> \n \n","listText":"📢请关注我的youtube频道：不二说价值。以确保收看所有完整的节目。📢 我会持续对优质公司进行估价，帮助虎友做出更合理的交易决策。欢迎评论留下自己想估价的股票，热门留言我会优先估价。✅配合视频站，我的空间站专属内容大幅增加，每月还会有独家现金福利哦！具体请看：<a href=\"https://laohu8.com/TW/140843402\" target=\"_blank\">十万刀空间站独家内容和丰富福利介绍</a><a target=\"_blank\" href=\"https://laohu8.com/S/BILI\">$哔哩哔哩(BILI)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/IQ\">$爱奇艺(IQ)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/NFLX\">$Netflix, Inc.(NFLX)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/BIDU\">$百度(BIDU)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/GOOG\">$谷歌(GOOG)$</a> ","text":"📢请关注我的youtube频道：不二说价值。以确保收看所有完整的节目。📢 我会持续对优质公司进行估价，帮助虎友做出更合理的交易决策。欢迎评论留下自己想估价的股票，热门留言我会优先估价。✅配合视频站，我的空间站专属内容大幅增加，每月还会有独家现金福利哦！具体请看：十万刀空间站独家内容和丰富福利介绍$哔哩哔哩(BILI)$ $爱奇艺(IQ)$ $Netflix, Inc.(NFLX)$ $百度(BIDU)$ $谷歌(GOOG)$","images":[{"img":"https://static.tigerbbs.com/5f230cb55b47dc8fd364965b5160cab6","width":"0","height":"0"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876397745","isVote":1,"tweetType":2,"object":{"id":"78b42b57ac2640bbb55b138315a8bba3","tweetId":"876397745","videoUrl":"https://1254107296.vod2.myqcloud.com/73ba5544vodgzp1254107296/8d7d3c03387702291639699256/fqPGAPa2TrsA.mp4","poster":"https://static.tigerbbs.com/5f230cb55b47dc8fd364965b5160cab6"},"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":859,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876566369,"gmtCreate":1637332840310,"gmtModify":1637332840696,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581839766583119","idStr":"3581839766583119"},"themes":[],"htmlText":"Like ","listText":"Like ","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/876566369","repostId":"1169563508","repostType":4,"repost":{"id":"1169563508","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637332340,"share":"https://www.laohu8.com/m/news/1169563508?lang=zh_CN&edition=full","pubTime":"2021-11-19 22:32","market":"us","language":"en","title":"S&P 500 opens little changed as investors assess Austria lockdown, tech stock strength<blockquote>由于投资者评估奥地利封锁和科技股走强，标普500开盘几乎没有变化</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1169563508","media":"Tiger Newspress","summary":"The Dow Jones Industrial Average and S&P 500 were under pressure Friday, as concern over a Covid-19 ","content":"<p>The Dow Jones Industrial Average and S&P 500 were under pressure Friday, as concern over a Covid-19 resurgence weighed on global markets.</p><p><blockquote>由于对Covid-19死灰复燃的担忧给全球市场带来压力，道琼斯工业平均指数和标普500周五面临压力。</blockquote></p><p> The Dow fell 57 points, or 0.5%, reversing course having earlier been in positive territory, and the S&P 500 fell 0.02%. The Nasdaq Composite added 0.3% as tech shares gained.</p><p><blockquote>道琼斯指数下跌57点，跌幅0.5%，扭转了早些时候的上涨趋势，标普500下跌0.02%。随着科技股上涨，纳斯达克综合指数上涨0.3%。</blockquote></p><p> \"The news is hitting European markets hard this morning as fears mount that the virus and restrictions will spread across the continent again,\" said Jim Reid, chief economist at Deutsche Bank, adding that \"the curveball might be the U.S.\" given lower rates of vaccination domestically than in Europe.</p><p><blockquote>德意志银行首席经济学家吉姆·里德表示：“今天早上，这一消息对欧洲市场造成了沉重打击，因为人们越来越担心病毒和限制措施将再次在整个欧洲大陆蔓延。”他补充说，“曲线球可能是美国。”鉴于国内疫苗接种率低于欧洲。</blockquote></p><p> \"So although all the headlines are in Europe at the moment, will the U.S. be more vulnerable than many European countries over the course of the full winter? Recent history suggests the US have a higher bar for economic restrictions related to covid but it also has a lower vaccination rate than their European peers,\" he added.</p><p><blockquote>“因此，尽管目前所有的头条新闻都在欧洲，但在整个冬天，美国会比许多欧洲国家更脆弱吗？最近的历史表明，美国对与新冠疫情相关的经济限制有更高的门槛，但它也有疫苗接种率低于欧洲同行，”他补充道。</blockquote></p><p> Meanwhile, Nasdaq futures pointed higher, bolstered by a jump in stocks associated with the \"stay-at-home\" trade that characterized much of 2020. Treasury yields, which have jumped in response to rising inflation fears, retreated early Friday as investors flocked to safe-haven assets. Brent crude (CL=F) sank by over 3%, reflecting jitters that lockdowns will curb energy demand.</p><p><blockquote>与此同时，受2020年大部分时间“居家”交易相关股票上涨的支撑，纳斯达克期货走高。因通胀担忧加剧而飙升的美国国债收益率周五早些时候回落，因为投资者纷纷涌向避险资产。布伦特原油(CL=F)下跌超过3%，反映出人们对封锁将抑制能源需求的担忧。</blockquote></p><p> On Thursday, The Dow (^DJI) fell 230 points (0.2%), pressured by a drop in shares of Cisco (CSCO). The computer networking company posted quarterlyresults after the bell Wednesdaythat fell shortof analysts' expectations due to component shortages andthe company issuingweaker-than-expected guidance. Yet the S&P 500 gained and tech<b>-</b>heavy Nasdaq — led by gains from Tesla (TSLA) and Nvidia (NVDA) — ended at all-time closing highs.</p><p><blockquote>周四，受思科(CSCO)股价下跌压力，道琼斯指数(^DJI)下跌230点(0.2%)。这家计算机网络公司周三盘后公布的季度业绩低于分析师预期，原因是零部件短缺以及该公司发布的指引弱于预期。然而，标普500和技术<b>-</b>在特斯拉（TSLA）和英伟达（NVDA）上涨的带动下，重磅纳斯达克收于历史收盘高点。</blockquote></p><p> There is no economic data on the calendar on Friday, however investors will be keeping a close eye on Washington, where the House is expected to pass President Joe Biden’s “Build Back Better” bill. The bill lays out the administration's plans to spend $1.85 trillion on education, healthcare and the climate.</p><p><blockquote>周五没有经济数据，但投资者将密切关注华盛顿，预计众议院将通过总统乔·拜登的“重建得更好”法案。该法案列出了政府在教育、医疗保健和气候方面支出1.85万亿美元的计划。</blockquote></p><p> Also in focus for the markets is Biden’s Federal Reserve chair nomination. Biden told reporters on Tuesday to expect the announcement of a nominee for Fed chair in \"the next four days.\" The White House appears to beweighing two options: reappoint current chair Jerome Powell or Fed governor Lael Brainard.</p><p><blockquote>市场还关注拜登的美联储主席提名。拜登周二告诉记者，预计美联储主席提名人将在“未来四天”宣布。白宫似乎正在权衡两种选择：重新任命现任主席杰罗姆·鲍威尔或美联储理事莱尔·布雷纳德。</blockquote></p><p> \"The market so far is believing that it will be Powell again, but any sort of a change would mean that they want to hear a reiteration of the monetary policy andforward expectations,\" Sonali Pier, Pimco's Managing Director and Portfolio Manager, told Yahoo Finance Live on Thursday.</p><p><blockquote>太平洋投资管理公司董事总经理兼投资组合经理索纳利·皮尔(Sonali Pier)对雅虎财经表示：“到目前为止，市场认为鲍威尔将再次当选，但任何形式的变化都意味着他们希望听到货币政策和前瞻性预期的重申。”周四直播。</blockquote></p><p> \"[That means] tapering, being at a pace of about $10 billion in treasuries, $5 billion in agency MBS, then thereafter seeing rate hikes but not a significant shift to be more hawkish,\" Pier added.</p><p><blockquote>皮尔补充道：“[这意味着]缩减规模，即国债规模约为100亿美元，机构MBS规模约为50亿美元，然后加息，但不会大幅转向更加鹰派。”</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 opens little changed as investors assess Austria lockdown, tech stock strength<blockquote>由于投资者评估奥地利封锁和科技股走强，标普500开盘几乎没有变化</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 opens little changed as investors assess Austria lockdown, tech stock strength<blockquote>由于投资者评估奥地利封锁和科技股走强，标普500开盘几乎没有变化</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-19 22:32</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>The Dow Jones Industrial Average and S&P 500 were under pressure Friday, as concern over a Covid-19 resurgence weighed on global markets.</p><p><blockquote>由于对Covid-19死灰复燃的担忧给全球市场带来压力，道琼斯工业平均指数和标普500周五面临压力。</blockquote></p><p> The Dow fell 57 points, or 0.5%, reversing course having earlier been in positive territory, and the S&P 500 fell 0.02%. The Nasdaq Composite added 0.3% as tech shares gained.</p><p><blockquote>道琼斯指数下跌57点，跌幅0.5%，扭转了早些时候的上涨趋势，标普500下跌0.02%。随着科技股上涨，纳斯达克综合指数上涨0.3%。</blockquote></p><p> \"The news is hitting European markets hard this morning as fears mount that the virus and restrictions will spread across the continent again,\" said Jim Reid, chief economist at Deutsche Bank, adding that \"the curveball might be the U.S.\" given lower rates of vaccination domestically than in Europe.</p><p><blockquote>德意志银行首席经济学家吉姆·里德表示：“今天早上，这一消息对欧洲市场造成了沉重打击，因为人们越来越担心病毒和限制措施将再次在整个欧洲大陆蔓延。”他补充说，“曲线球可能是美国。”鉴于国内疫苗接种率低于欧洲。</blockquote></p><p> \"So although all the headlines are in Europe at the moment, will the U.S. be more vulnerable than many European countries over the course of the full winter? Recent history suggests the US have a higher bar for economic restrictions related to covid but it also has a lower vaccination rate than their European peers,\" he added.</p><p><blockquote>“因此，尽管目前所有的头条新闻都在欧洲，但在整个冬天，美国会比许多欧洲国家更脆弱吗？最近的历史表明，美国对与新冠疫情相关的经济限制有更高的门槛，但它也有疫苗接种率低于欧洲同行，”他补充道。</blockquote></p><p> Meanwhile, Nasdaq futures pointed higher, bolstered by a jump in stocks associated with the \"stay-at-home\" trade that characterized much of 2020. Treasury yields, which have jumped in response to rising inflation fears, retreated early Friday as investors flocked to safe-haven assets. Brent crude (CL=F) sank by over 3%, reflecting jitters that lockdowns will curb energy demand.</p><p><blockquote>与此同时，受2020年大部分时间“居家”交易相关股票上涨的支撑，纳斯达克期货走高。因通胀担忧加剧而飙升的美国国债收益率周五早些时候回落，因为投资者纷纷涌向避险资产。布伦特原油(CL=F)下跌超过3%，反映出人们对封锁将抑制能源需求的担忧。</blockquote></p><p> On Thursday, The Dow (^DJI) fell 230 points (0.2%), pressured by a drop in shares of Cisco (CSCO). The computer networking company posted quarterlyresults after the bell Wednesdaythat fell shortof analysts' expectations due to component shortages andthe company issuingweaker-than-expected guidance. Yet the S&P 500 gained and tech<b>-</b>heavy Nasdaq — led by gains from Tesla (TSLA) and Nvidia (NVDA) — ended at all-time closing highs.</p><p><blockquote>周四，受思科(CSCO)股价下跌压力，道琼斯指数(^DJI)下跌230点(0.2%)。这家计算机网络公司周三盘后公布的季度业绩低于分析师预期，原因是零部件短缺以及该公司发布的指引弱于预期。然而，标普500和技术<b>-</b>在特斯拉（TSLA）和英伟达（NVDA）上涨的带动下，重磅纳斯达克收于历史收盘高点。</blockquote></p><p> There is no economic data on the calendar on Friday, however investors will be keeping a close eye on Washington, where the House is expected to pass President Joe Biden’s “Build Back Better” bill. The bill lays out the administration's plans to spend $1.85 trillion on education, healthcare and the climate.</p><p><blockquote>周五没有经济数据，但投资者将密切关注华盛顿，预计众议院将通过总统乔·拜登的“重建得更好”法案。该法案列出了政府在教育、医疗保健和气候方面支出1.85万亿美元的计划。</blockquote></p><p> Also in focus for the markets is Biden’s Federal Reserve chair nomination. Biden told reporters on Tuesday to expect the announcement of a nominee for Fed chair in \"the next four days.\" The White House appears to beweighing two options: reappoint current chair Jerome Powell or Fed governor Lael Brainard.</p><p><blockquote>市场还关注拜登的美联储主席提名。拜登周二告诉记者，预计美联储主席提名人将在“未来四天”宣布。白宫似乎正在权衡两种选择：重新任命现任主席杰罗姆·鲍威尔或美联储理事莱尔·布雷纳德。</blockquote></p><p> \"The market so far is believing that it will be Powell again, but any sort of a change would mean that they want to hear a reiteration of the monetary policy andforward expectations,\" Sonali Pier, Pimco's Managing Director and Portfolio Manager, told Yahoo Finance Live on Thursday.</p><p><blockquote>太平洋投资管理公司董事总经理兼投资组合经理索纳利·皮尔(Sonali Pier)对雅虎财经表示：“到目前为止，市场认为鲍威尔将再次当选，但任何形式的变化都意味着他们希望听到货币政策和前瞻性预期的重申。”周四直播。</blockquote></p><p> \"[That means] tapering, being at a pace of about $10 billion in treasuries, $5 billion in agency MBS, then thereafter seeing rate hikes but not a significant shift to be more hawkish,\" Pier added.</p><p><blockquote>皮尔补充道：“[这意味着]缩减规模，即国债规模约为100亿美元，机构MBS规模约为50亿美元，然后加息，但不会大幅转向更加鹰派。”</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169563508","content_text":"The Dow Jones Industrial Average and S&P 500 were under pressure Friday, as concern over a Covid-19 resurgence weighed on global markets.\nThe Dow fell 57 points, or 0.5%, reversing course having earlier been in positive territory, and the S&P 500 fell 0.02%. The Nasdaq Composite added 0.3% as tech shares gained.\n\"The news is hitting European markets hard this morning as fears mount that the virus and restrictions will spread across the continent again,\" said Jim Reid, chief economist at Deutsche Bank, adding that \"the curveball might be the U.S.\" given lower rates of vaccination domestically than in Europe.\n\"So although all the headlines are in Europe at the moment, will the U.S. be more vulnerable than many European countries over the course of the full winter? Recent history suggests the US have a higher bar for economic restrictions related to covid but it also has a lower vaccination rate than their European peers,\" he added.\nMeanwhile, Nasdaq futures pointed higher, bolstered by a jump in stocks associated with the \"stay-at-home\" trade that characterized much of 2020. Treasury yields, which have jumped in response to rising inflation fears, retreated early Friday as investors flocked to safe-haven assets. Brent crude (CL=F) sank by over 3%, reflecting jitters that lockdowns will curb energy demand.\nOn Thursday, The Dow (^DJI) fell 230 points (0.2%), pressured by a drop in shares of Cisco (CSCO). The computer networking company posted quarterlyresults after the bell Wednesdaythat fell shortof analysts' expectations due to component shortages andthe company issuingweaker-than-expected guidance. Yet the S&P 500 gained and tech-heavy Nasdaq — led by gains from Tesla (TSLA) and Nvidia (NVDA) — ended at all-time closing highs.\nThere is no economic data on the calendar on Friday, however investors will be keeping a close eye on Washington, where the House is expected to pass President Joe Biden’s “Build Back Better” bill. The bill lays out the administration's plans to spend $1.85 trillion on education, healthcare and the climate.\nAlso in focus for the markets is Biden’s Federal Reserve chair nomination. Biden told reporters on Tuesday to expect the announcement of a nominee for Fed chair in \"the next four days.\" The White House appears to beweighing two options: reappoint current chair Jerome Powell or Fed governor Lael Brainard.\n\"The market so far is believing that it will be Powell again, but any sort of a change would mean that they want to hear a reiteration of the monetary policy andforward expectations,\" Sonali Pier, Pimco's Managing Director and Portfolio Manager, told Yahoo Finance Live on Thursday.\n\"[That means] tapering, being at a pace of about $10 billion in treasuries, $5 billion in agency MBS, then thereafter seeing rate hikes but not a significant shift to be more hawkish,\" Pier added.","news_type":1,"symbols_score_info":{".DJI":0.9,".SPX":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":832,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876960028,"gmtCreate":1637249436694,"gmtModify":1637249436841,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581839766583119","idStr":"3581839766583119"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/876960028","repostId":"1125341334","repostType":4,"isVote":1,"tweetType":1,"viewCount":1052,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878364395,"gmtCreate":1637151250224,"gmtModify":1637151250365,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581839766583119","idStr":"3581839766583119"},"themes":[],"htmlText":"Like ","listText":"Like ","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878364395","repostId":"2184847528","repostType":4,"repost":{"id":"2184847528","kind":"highlight","pubTimestamp":1637108100,"share":"https://www.laohu8.com/m/news/2184847528?lang=zh_CN&edition=full","pubTime":"2021-11-17 08:15","market":"us","language":"en","title":"A new Big Three? Rivian and Lucid's valuations are accelerating past Ford, GM<blockquote>新的三巨头？Rivian和Lucid的估值正在加速超过福特和通用汽车</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2184847528","media":"MarketWatch","summary":"Rivian, Lucid pass Ford as the hunt for the next Tesla continues\nRivian stock is up 61% since its fi","content":"<p>Rivian, Lucid pass Ford as the hunt for the next Tesla continues</p><p><blockquote>Rivian、Lucid超越福特，继续寻找下一个特斯拉</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b65c1d2713c7d614783579796548161c\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Rivian stock is up 61% since its first trade last week. Getty Images</span></p><p><blockquote><p class=\"t-img-caption\"><span>自上周首次交易以来，Rivian股价已上涨61%。盖蒂图片</span></p></blockquote></p><p> Rivian Automotive Inc.'s market valuation is already nearly double that of Ford Motor Co. and zoomed past General Motors Co. a week into the electric-vehicle startup's life as a public company, while rival Lucid Motors' market value closed in on GM's and topped Ford's on Tuesday, underscoring investors' appetite for EV makers and the hunt for the next Tesla Inc.</p><p><blockquote>Rivian汽车公司的市值已经几乎是福特汽车公司的两倍，并且在这家电动汽车初创公司上市一周后就超过了通用汽车公司，而竞争对手Lucid Motors的市值则接近通用汽车公司。周二，通用汽车的市值超过了福特，突显了投资者对电动汽车制造商的兴趣以及对下一个特斯拉公司的寻找。</blockquote></p><p> Rivian went public last Tuesday after the biggest initial public offering of the year and seventh-largest U.S. IPO since the mid-1990s. The stock ended 15% higher on Tuesday, boosting the company's valuation a little over $148 billion.</p><p><blockquote>Rivian上周二上市，这是今年最大的首次公开募股，也是自20世纪90年代中期以来美国第七大IPO。该股周二收盘上涨15%，使公司估值略高于1480亿美元。</blockquote></p><p> That compares to Ford's valuation around $78 billion and GM's at about $91 billion on Tuesday. Tesla is the highest-valued auto maker in the U.S., at a market capitalization above $1 trillion.</p><p><blockquote>相比之下，福特的估值约为780亿美元，通用汽车周二的估值约为910亿美元。特斯拉是美国市值最高的汽车制造商，市值超过1万亿美元。</blockquote></p><p> Rivian stock has gained 61% since its first trade of $106.75 last week, and 121% from its IPO price of $78.</p><p><blockquote>自上周首次交易106.75美元以来，Rivian股价已上涨61%，较78美元的IPO价格上涨121%。</blockquote></p><p> Lucid shares jumped 24% to close at $55.52 on Tuesday, pushing the EV maker's valuation to slightly under $89 billion. That was the stock's highest close since Feb. 22, when it closed at $57.37.</p><p><blockquote>Lucid股价周二上涨24%，收于55.52美元，使这家电动汽车制造商的估值略低于890亿美元。这是该股自2月22日以来的最高收盘价，当时收于57.37美元。</blockquote></p><p> Lucid, which has been hailed as the \"Tesla/Ferrari\" of EVs and focuses on the high-end market, went public through a blank-check company deal and the stock started trading on the Nasdaq in July. The EV maker said Monday its orders rose 30%, with \"significant\" demand for its Lucid Air luxury EV.</p><p><blockquote>Lucid被誉为电动汽车的“特斯拉/法拉利”，专注于高端市场，通过空白支票公司交易上市，该股于7月开始在纳斯达克交易。这家电动汽车制造商周一表示，其订单增长了30%，对其Lucid Air豪华电动汽车的需求“巨大”。</blockquote></p><p> Rivian already has delivered a few limited-edition R1Ts, its two-row, five-seat pickup truck, and plans to launch an SUV, the R1S, in December. Volume sales of the pickup and the SUV are expected to begin in December and January.</p><p><blockquote>Rivian已经交付了几辆限量版R1T（两排五座皮卡），并计划于12月推出SUV R1S。皮卡和SUV预计将于12月和1月开始批量销售。</blockquote></p><p> Rivian markets its vehicles as \"electric adventure vehicles\" with prices starting at the low $70,000s, which has led some to question the size of its market, with cheaper electric pickups, including Ford's Lightning F-150, slated for next year.</p><p><blockquote>Rivian将其汽车宣传为“电动冒险车”，起价低至70,000美元，这导致一些人质疑其市场规模，更便宜的电动皮卡，包括福特的Lightning F-150，计划于明年上市。</blockquote></p><p> The Ford Lightning is expected to start at about $40,000, and the cachet of being the electric version of the U.S. best-selling vehicle for decades comes free of charge. GM plans to unveil an electric Silverado next year as well.</p><p><blockquote>福特Lightning预计起价约为40,000美元，几十年来作为美国最畅销汽车的电动版的声望是免费的。通用汽车还计划明年推出电动索罗德。</blockquote></p><p></p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A new Big Three? Rivian and Lucid's valuations are accelerating past Ford, GM<blockquote>新的三巨头？Rivian和Lucid的估值正在加速超过福特和通用汽车</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA new Big Three? Rivian and Lucid's valuations are accelerating past Ford, GM<blockquote>新的三巨头？Rivian和Lucid的估值正在加速超过福特和通用汽车</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">MarketWatch</strong><span class=\"h-time small\">2021-11-17 08:15</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Rivian, Lucid pass Ford as the hunt for the next Tesla continues</p><p><blockquote>Rivian、Lucid超越福特，继续寻找下一个特斯拉</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b65c1d2713c7d614783579796548161c\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Rivian stock is up 61% since its first trade last week. Getty Images</span></p><p><blockquote><p class=\"t-img-caption\"><span>自上周首次交易以来，Rivian股价已上涨61%。盖蒂图片</span></p></blockquote></p><p> Rivian Automotive Inc.'s market valuation is already nearly double that of Ford Motor Co. and zoomed past General Motors Co. a week into the electric-vehicle startup's life as a public company, while rival Lucid Motors' market value closed in on GM's and topped Ford's on Tuesday, underscoring investors' appetite for EV makers and the hunt for the next Tesla Inc.</p><p><blockquote>Rivian汽车公司的市值已经几乎是福特汽车公司的两倍，并且在这家电动汽车初创公司上市一周后就超过了通用汽车公司，而竞争对手Lucid Motors的市值则接近通用汽车公司。周二，通用汽车的市值超过了福特，突显了投资者对电动汽车制造商的兴趣以及对下一个特斯拉公司的寻找。</blockquote></p><p> Rivian went public last Tuesday after the biggest initial public offering of the year and seventh-largest U.S. IPO since the mid-1990s. The stock ended 15% higher on Tuesday, boosting the company's valuation a little over $148 billion.</p><p><blockquote>Rivian上周二上市，这是今年最大的首次公开募股，也是自20世纪90年代中期以来美国第七大IPO。该股周二收盘上涨15%，使公司估值略高于1480亿美元。</blockquote></p><p> That compares to Ford's valuation around $78 billion and GM's at about $91 billion on Tuesday. Tesla is the highest-valued auto maker in the U.S., at a market capitalization above $1 trillion.</p><p><blockquote>相比之下，福特的估值约为780亿美元，通用汽车周二的估值约为910亿美元。特斯拉是美国市值最高的汽车制造商，市值超过1万亿美元。</blockquote></p><p> Rivian stock has gained 61% since its first trade of $106.75 last week, and 121% from its IPO price of $78.</p><p><blockquote>自上周首次交易106.75美元以来，Rivian股价已上涨61%，较78美元的IPO价格上涨121%。</blockquote></p><p> Lucid shares jumped 24% to close at $55.52 on Tuesday, pushing the EV maker's valuation to slightly under $89 billion. That was the stock's highest close since Feb. 22, when it closed at $57.37.</p><p><blockquote>Lucid股价周二上涨24%，收于55.52美元，使这家电动汽车制造商的估值略低于890亿美元。这是该股自2月22日以来的最高收盘价，当时收于57.37美元。</blockquote></p><p> Lucid, which has been hailed as the \"Tesla/Ferrari\" of EVs and focuses on the high-end market, went public through a blank-check company deal and the stock started trading on the Nasdaq in July. The EV maker said Monday its orders rose 30%, with \"significant\" demand for its Lucid Air luxury EV.</p><p><blockquote>Lucid被誉为电动汽车的“特斯拉/法拉利”，专注于高端市场，通过空白支票公司交易上市，该股于7月开始在纳斯达克交易。这家电动汽车制造商周一表示，其订单增长了30%，对其Lucid Air豪华电动汽车的需求“巨大”。</blockquote></p><p> Rivian already has delivered a few limited-edition R1Ts, its two-row, five-seat pickup truck, and plans to launch an SUV, the R1S, in December. Volume sales of the pickup and the SUV are expected to begin in December and January.</p><p><blockquote>Rivian已经交付了几辆限量版R1T（两排五座皮卡），并计划于12月推出SUV R1S。皮卡和SUV预计将于12月和1月开始批量销售。</blockquote></p><p> Rivian markets its vehicles as \"electric adventure vehicles\" with prices starting at the low $70,000s, which has led some to question the size of its market, with cheaper electric pickups, including Ford's Lightning F-150, slated for next year.</p><p><blockquote>Rivian将其汽车宣传为“电动冒险车”，起价低至70,000美元，这导致一些人质疑其市场规模，更便宜的电动皮卡，包括福特的Lightning F-150，计划于明年上市。</blockquote></p><p> The Ford Lightning is expected to start at about $40,000, and the cachet of being the electric version of the U.S. best-selling vehicle for decades comes free of charge. GM plans to unveil an electric Silverado next year as well.</p><p><blockquote>福特Lightning预计起价约为40,000美元，几十年来作为美国最畅销汽车的电动版的声望是免费的。通用汽车还计划明年推出电动索罗德。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/story/a-new-big-three-rivian-and-lucids-valuations-are-accelerating-past-ford-gm-11637102012?mod=home-page\">MarketWatch</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4566":"资本集团","LCID":"Lucid Group Inc","BK4099":"汽车制造商","GM":"通用汽车","BK4561":"索罗斯持仓","RIVN":"Rivian Automotive, Inc.","BK4555":"新能源车","BK4559":"巴菲特持仓"},"source_url":"https://www.marketwatch.com/story/a-new-big-three-rivian-and-lucids-valuations-are-accelerating-past-ford-gm-11637102012?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2184847528","content_text":"Rivian, Lucid pass Ford as the hunt for the next Tesla continues\nRivian stock is up 61% since its first trade last week. Getty Images\nRivian Automotive Inc.'s market valuation is already nearly double that of Ford Motor Co. and zoomed past General Motors Co. a week into the electric-vehicle startup's life as a public company, while rival Lucid Motors' market value closed in on GM's and topped Ford's on Tuesday, underscoring investors' appetite for EV makers and the hunt for the next Tesla Inc.\nRivian went public last Tuesday after the biggest initial public offering of the year and seventh-largest U.S. IPO since the mid-1990s. The stock ended 15% higher on Tuesday, boosting the company's valuation a little over $148 billion.\nThat compares to Ford's valuation around $78 billion and GM's at about $91 billion on Tuesday. Tesla is the highest-valued auto maker in the U.S., at a market capitalization above $1 trillion.\nRivian stock has gained 61% since its first trade of $106.75 last week, and 121% from its IPO price of $78.\nLucid shares jumped 24% to close at $55.52 on Tuesday, pushing the EV maker's valuation to slightly under $89 billion. That was the stock's highest close since Feb. 22, when it closed at $57.37.\nLucid, which has been hailed as the \"Tesla/Ferrari\" of EVs and focuses on the high-end market, went public through a blank-check company deal and the stock started trading on the Nasdaq in July. The EV maker said Monday its orders rose 30%, with \"significant\" demand for its Lucid Air luxury EV.\nRivian already has delivered a few limited-edition R1Ts, its two-row, five-seat pickup truck, and plans to launch an SUV, the R1S, in December. Volume sales of the pickup and the SUV are expected to begin in December and January.\nRivian markets its vehicles as \"electric adventure vehicles\" with prices starting at the low $70,000s, which has led some to question the size of its market, with cheaper electric pickups, including Ford's Lightning F-150, slated for next year.\nThe Ford Lightning is expected to start at about $40,000, and the cachet of being the electric version of the U.S. best-selling vehicle for decades comes free of charge. GM plans to unveil an electric Silverado next year as well.","news_type":1,"symbols_score_info":{"GM":0.9,"LCID":0.9,"RIVN":0.9}},"isVote":1,"tweetType":1,"viewCount":863,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871591744,"gmtCreate":1637078847307,"gmtModify":1637078864402,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581839766583119","idStr":"3581839766583119"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871591744","repostId":"1112207087","repostType":4,"isVote":1,"tweetType":1,"viewCount":1069,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873139879,"gmtCreate":1636875364746,"gmtModify":1636875364883,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581839766583119","idStr":"3581839766583119"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873139879","repostId":"1103944030","repostType":4,"isVote":1,"tweetType":1,"viewCount":1073,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879722773,"gmtCreate":1636776252338,"gmtModify":1636776252439,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581839766583119","idStr":"3581839766583119"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/879722773","repostId":"1102251183","repostType":4,"repost":{"id":"1102251183","kind":"news","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=zh_CN&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上，辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时，听起来很头晕。就在几天前，他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说：“你能够打破这种类型的世界纪录，同时偶然获得大满贯，这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利：在短短10个月内开发出了一种效果惊人的Covid-19疫苗，一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前，辉瑞（股票代码：PFE）首席执行官阿尔伯特·布尔拉（Albert Bourla）要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品，留下了一家纯粹的生物制药公司，该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中，<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而，随着对全球疫苗分配不平等的批评越来越多，继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中，低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家，该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).</p><p><blockquote>数据公布当天，辉瑞股价飙升10.9%，创下至少20年来的最佳单日表现。尽管如此，由于该股目前易手价格约为50美元，投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍，低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的，但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上，但对于长期投资者来说，这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室，但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期，辉瑞公司将其工作分为与BioNTech在疫苗上的合作和对Covid-19药丸的探索。疫苗工作规模巨大；多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队，拥有相当适中的资源，”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目，其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&D is better than people had thought.”</p><p><blockquote>“（辉瑞的）制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而，辉瑞文库中的蛋白酶抑制剂已经静脉内施用，并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药，这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应，”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物，这个过程通常可能需要数年时间，但他们在几个月内就完成了。“在这里，四年变成了四个月，”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验，包括一项针对高风险患者，一项针对非高风险患者，以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中，该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示：“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级，目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示，在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前，她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级，”她说。“在这些事情发生之前，我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时，Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望，呼吁该公司提高产量，以便能够以非营利价格向低收入国家提供更多剂量，一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续，辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候，辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平，告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗，捐赠给贫穷国家，并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面，辉瑞仅表示将为较贫穷国家提供分级定价，与其疫苗采取的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议，允许其药丸在全球范围内获得许可，无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示，辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择，”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底，活动人士在布尔拉家外抗议，呼吁辉瑞分享其疫苗制造技术，并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评，使辉瑞公司相对受到华盛顿的青睐，并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-11-13 11:00</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上，辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时，听起来很头晕。就在几天前，他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说：“你能够打破这种类型的世界纪录，同时偶然获得大满贯，这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利：在短短10个月内开发出了一种效果惊人的Covid-19疫苗，一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前，辉瑞（股票代码：PFE）首席执行官阿尔伯特·布尔拉（Albert Bourla）要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品，留下了一家纯粹的生物制药公司，该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中，<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而，随着对全球疫苗分配不平等的批评越来越多，继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中，低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家，该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).</p><p><blockquote>数据公布当天，辉瑞股价飙升10.9%，创下至少20年来的最佳单日表现。尽管如此，由于该股目前易手价格约为50美元，投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍，低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的，但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上，但对于长期投资者来说，这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室，但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期，辉瑞公司将其工作分为与BioNTech在疫苗上的合作和对Covid-19药丸的探索。疫苗工作规模巨大；多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队，拥有相当适中的资源，”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目，其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&D is better than people had thought.”</p><p><blockquote>“（辉瑞的）制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而，辉瑞文库中的蛋白酶抑制剂已经静脉内施用，并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药，这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应，”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物，这个过程通常可能需要数年时间，但他们在几个月内就完成了。“在这里，四年变成了四个月，”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验，包括一项针对高风险患者，一项针对非高风险患者，以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中，该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示：“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级，目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示，在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前，她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级，”她说。“在这些事情发生之前，我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时，Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望，呼吁该公司提高产量，以便能够以非营利价格向低收入国家提供更多剂量，一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续，辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候，辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平，告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗，捐赠给贫穷国家，并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面，辉瑞仅表示将为较贫穷国家提供分级定价，与其疫苗采取的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议，允许其药丸在全球范围内获得许可，无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示，辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择，”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底，活动人士在布尔拉家外抗议，呼吁辉瑞分享其疫苗制造技术，并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评，使辉瑞公司相对受到华盛顿的青睐，并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":871,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879659224,"gmtCreate":1636720892357,"gmtModify":1636720905943,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581839766583119","idStr":"3581839766583119"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879659224","repostId":"2182100092","repostType":4,"isVote":1,"tweetType":1,"viewCount":838,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":838488980,"gmtCreate":1629424028040,"gmtModify":1633684940841,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581839766583119","authorIdStr":"3581839766583119"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/838488980","repostId":"2160915795","repostType":4,"isVote":1,"tweetType":1,"viewCount":383,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":876960028,"gmtCreate":1637249436694,"gmtModify":1637249436841,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581839766583119","authorIdStr":"3581839766583119"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/876960028","repostId":"1125341334","repostType":4,"isVote":1,"tweetType":1,"viewCount":1052,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840951124,"gmtCreate":1635578276546,"gmtModify":1635578276687,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581839766583119","authorIdStr":"3581839766583119"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/840951124","repostId":"2179169244","repostType":4,"isVote":1,"tweetType":1,"viewCount":563,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":835562228,"gmtCreate":1629727521164,"gmtModify":1633682891590,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581839766583119","authorIdStr":"3581839766583119"},"themes":[],"htmlText":"Like ","listText":"Like ","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/835562228","repostId":"2161747692","repostType":4,"isVote":1,"tweetType":1,"viewCount":464,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":895688724,"gmtCreate":1628739200668,"gmtModify":1633689857341,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581839766583119","authorIdStr":"3581839766583119"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/895688724","repostId":"1146833505","repostType":4,"isVote":1,"tweetType":1,"viewCount":710,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881461542,"gmtCreate":1631377415686,"gmtModify":1631890133055,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581839766583119","authorIdStr":"3581839766583119"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/881461542","repostId":"2166372458","repostType":4,"isVote":1,"tweetType":1,"viewCount":780,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":823787413,"gmtCreate":1633662630906,"gmtModify":1633662631216,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581839766583119","authorIdStr":"3581839766583119"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/823787413","repostId":"1163018074","repostType":4,"isVote":1,"tweetType":1,"viewCount":535,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":811302152,"gmtCreate":1630287589176,"gmtModify":1704957820352,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581839766583119","authorIdStr":"3581839766583119"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/811302152","repostId":"2163776380","repostType":4,"isVote":1,"tweetType":1,"viewCount":373,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":147675168,"gmtCreate":1626357885254,"gmtModify":1633927539421,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581839766583119","authorIdStr":"3581839766583119"},"themes":[],"htmlText":"Like please ","listText":"Like please ","text":"Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/147675168","repostId":"2151529000","repostType":4,"isVote":1,"tweetType":1,"viewCount":649,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":855489153,"gmtCreate":1635390318267,"gmtModify":1635390318371,"author":{"id":"3581839766583119","authorId":"3581839766583119","name":"460e6297","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581839766583119","authorIdStr":"3581839766583119"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/855489153","repostId":"2178234765","repostType":4,"isVote":1,"tweetType":1,"viewCount":752,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}
